drugset / Trial / NCT03197324
Bexagliflozin Drug/Drug Interaction Study With Digoxin
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to examine the drug-drug interaction in your body when given the study drug, bexagliflozin, with the heart failure medication digoxin. The study will evaluate whether bexagliflozin effects the amount of digoxin in your blood and how safe the study drug is and how well the study drug is tolerated when taken with digoxin.
Timeline
- Start
- 2017-07-24
- Primary completion
- 2017-09-17
- Completion
- 2017-09-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bexagliflozin | Small molecule | 20 mg | Oral |
| Comparator | Digoxin | Other / unclassified | 0.5 mg | Oral |